[go: up one dir, main page]

AU4807293A - Methods for maturing precursor b cells - Google Patents

Methods for maturing precursor b cells

Info

Publication number
AU4807293A
AU4807293A AU48072/93A AU4807293A AU4807293A AU 4807293 A AU4807293 A AU 4807293A AU 48072/93 A AU48072/93 A AU 48072/93A AU 4807293 A AU4807293 A AU 4807293A AU 4807293 A AU4807293 A AU 4807293A
Authority
AU
Australia
Prior art keywords
maturing
precursor
cells
methods
maturing precursor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48072/93A
Inventor
Jan De Vries
Juha Punnonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU4807293A publication Critical patent/AU4807293A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/13—B-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU48072/93A 1992-08-21 1993-08-18 Methods for maturing precursor b cells Abandoned AU4807293A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93346192A 1992-08-21 1992-08-21
US933461 1992-08-21
PCT/US1993/007644 WO1994004658A1 (en) 1992-08-21 1993-08-18 Methods for maturing precursor b cells

Publications (1)

Publication Number Publication Date
AU4807293A true AU4807293A (en) 1994-03-15

Family

ID=25464008

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48072/93A Abandoned AU4807293A (en) 1992-08-21 1993-08-18 Methods for maturing precursor b cells

Country Status (2)

Country Link
AU (1) AU4807293A (en)
WO (1) WO1994004658A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2206449A1 (en) * 1994-12-01 1996-06-06 Beth Israel Deaconess Medical Center, Inc. In vitro t-lymphopoiesis system
GB2301114A (en) * 1995-05-24 1996-11-27 Bradley Michael John Stringer Method for controlling differentiation of precursor cells

Also Published As

Publication number Publication date
WO1994004658A1 (en) 1994-03-03

Similar Documents

Publication Publication Date Title
AU4754393A (en) Cell culture insert
AU4754493A (en) Cell culture insert
AU1157695A (en) Hybrid growth factors
AU5050193A (en) Sollar cell
AU4166393A (en) Auto-reclosers
AU5120693A (en) Separator
AU3501293A (en) Compost maker
AU4243993A (en) New process for producing 7beta-substituted-4-aza-5alpha-androstan-3-ones
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU3042892A (en) Rockbolt
AU4410893A (en) Electrolytic cell
AU3717993A (en) Separator
AU4177593A (en) Benzophenonehydrazones
AU3752293A (en) Photovoltaic cells
AU4156393A (en) Heterocyclyltriazolinones
AU1969888A (en) Oriented polypropylene films
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU4164793A (en) Heterocyclyltriazolinones
AU2283497A (en) Methods for increasing the maturation of cells
AU3666393A (en) Solution draw method
AU6795087A (en) Polyarylethersulfone
AU5153993A (en) Moulding process
AU4807293A (en) Methods for maturing precursor b cells
AU2339688A (en) Track-guidable omnibus